Senate Majority Leader Harry ReidHarry Mason ReidDems walk tightrope on Pompeo nomination The Memo: Teens rankle the right with gun activism Dems to party: Go on offense with Trump’s alleged affairs MORE (D-Nev.) announced an agreement on amendments Wednesday that will finally allow a Food and Drug Administration bill to move forward. The deal should lead to passage of the bill on Thursday, ending several days of uncertainty.

Under the agreement, the Senate will consider 17 amendments to the bill, the Food and Drug Administration Safety and Innovation Act (S. 3187), which reauthorizes a user-fee program for drug companies seeking FDA approval. The Senate will debate amendments until Thursday at 2 p.m. After votes on the amendments, the Senate will vote on the bill itself.

ADVERTISEMENT
The agreement marks an end to a standstill over which amendments to consider, a problem that has slowed Senate work on several bills throughout the 112th Congress.
   
"I appreciate everyone's help and it takes everyone's help to get where we are," Reid said on the Senate floor after the deal was reached.

Senate Minority Leader Mitch McConnellAddison (Mitch) Mitchell McConnell32 male senators back Senate women's calls to change harassment rules Duckworth brings her baby to Senate vote, drawing a crowd FreedomWorks backs Jim Jordan for House Speaker MORE (R-Ky.) said the deal was a "good agreement that allows us to go forward on the FDA bill with appropriate amendments."

Under the agreement, four of the 17 amendments will require 60 votes for passage. One of these, from Sen. John McCainJohn Sidney McCainHeitkamp becomes first Dem to back Pompeo for secretary of State Senate committee sets Monday vote even as Pompeo appears to lack support Trump checkmates Democrats in sending Pompeo to North Korea MORE (R-Ariz.), would require Health and Human Services Secretary Kathleen SebeliusKathleen SebeliusTrump administration's reforms could make welfare work again Pro-dependency advocates miss the mark in attacking Kansas welfare reform Pence breaks tie to confirm Trump's pick for religious ambassador MORE to issue regulations allowing the importation of prescription drugs from Canada, within six months after the language becomes law.
 
Language from Sen. Bernie SandersBernard (Bernie) SandersSanders, Warren, O’Rourke inspire patriotic small donor waves Bill Press reflects on Clinton, Sanders and a life in politics Overnight Health Care: GOP pushes stiff work requirements for food stamps | Johnny Isakson opens up about family's tragic loss to opioids | Republicans refuse to back vulnerable Dem's opioids bill | Dems offer new public option plan MORE (I-Vt.) would take away exclusive drug marketing rights from companies found to be guilty of fraud. An amendment from Sen. Lisa MurkowskiLisa Ann MurkowskiSenators press administration on mental health parity Overnight Energy: Watchdogs unveil findings on EPA, Interior controversies | GAO says EPA violated law with soundproof booth | IG says Zinke could have avoided charter flight | GOP chair probes Pruitt's four email addresses GOP fractures over push to protect Russia probe MORE (R-Alaska) would limit the ability of the government to approve genetically modified fish or other marine wildlife. The fourth amendment requiring 60 votes was offered by Sen. Jeff Bingaman (D-N.M.); his language is aimed at ending delays in getting approval of generic drugs.

Among the remaining amendments are two that set up a fight over how much the FDA should be able to regulate dietary supplements. One amendment from Sen. Dick DurbinRichard (Dick) Joseph DurbinHannity, Kimmel, Farrow among Time's '100 Most Influential' The Hill's Morning Report: 200 Days to the Election Dems walk tightrope on Pompeo nomination MORE (D-Ill.) would require dietary supplement makers to register with the FDA, while the other from Sen. Rand PaulRandal (Rand) Howard PaulHeitkamp becomes first Dem to back Pompeo for secretary of State Senate committee sets Monday vote even as Pompeo appears to lack support Trump checkmates Democrats in sending Pompeo to North Korea MORE (R-Ky.) would prevent the government from taking any action to limit claims that a food supplement has certain mitigating effects against diseases. 

Details on the other amendments that could be voted on follow here, although some of these were expected to be withdrawn.

Sen. Ben CardinBenjamin (Ben) Louis CardinThe Hill's 12:30 Report Dems give muted praise to Pompeo-Kim meeting Key Dem to oppose Pompeo nomination MORE (D-Md.) -- requiring the FDA to devise a plan to educate people about the risks of various medical products.

Sen. Charles GrassleyCharles (Chuck) Ernest GrassleyGrassley: McConnell doesn't control my committee Senate panel punts Mueller protection bill to next week GOP senator: Congress needs ‘to move on’ from Russia probe MORE (R-Iowa) -- providing protections for the commissioned corps of the public health service.

Sen. Joseph Manchin (D-W.Va.) -- to reclassify the pain reliever hydrocodone under the controlled substances act.

Sen. Rob PortmanRobert (Rob) Jones PortmanTax rules will be subject to more OMB review under new memo Ending sex trafficking tomorrow requires preventing child abuse today Doctors bristle at push for opioid prescription limits MORE (R-Ohio) -- requiring the government to establish a system for facilitating the exchange of prescription drug information across state lines.

Sen. Jack ReedJohn (Jack) Francis ReedDems walk tightrope on Pompeo nomination Dem senators call on FCC to protect against robocalls Senate Dems press Trump on legal justification for potential Syria strike MORE (D-R.I.) -- setting phased-in compliance dates for a rule on sunscreen labeling.

Sen. Tom CoburnThomas (Tom) Allen CoburnPension insolvency crisis only grows as Congress sits on its hands Paul Ryan should realize that federal earmarks are the currency of cronyism Republicans in Congress shouldn't try to bring back earmarks MORE (R-Okla.) -- setting rules on employee performance awards.

Coburn -- requiring an audit of the drug approval process.

Sen. Richard BurrRichard Mauze BurrSenators express concerns over Haspel's 'destruction of evidence' Overnight Cybersecurity: US, UK blame Russia for global cyberattacks | Top cyber official leaving White House | Zuckerberg to meet EU digital chief Senators, state officials to meet on election cybersecurity bill MORE (R-N.C.) -- allowing members of Congress and their staffs to attend certain negotiations between the FDA and the regulated industry. Burr said on the Senate floor after the deal was announced that he would not force a vote on this language.